H.C. Wainwright reiterated coverage on Verastem with a new price target

3/24/25 7:46:47 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright reiterated coverage of Verastem with a rating of Buy and set a new price target of $10.00 from $7.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VSTM

Date	Price Target	Rating	Analyst
4/10/2025	$15.00	Buy	Jefferies
3/24/2025	$7.00 → $10.00	Buy	H.C. Wainwright
12/31/2024	$13.00 → $20.00	Buy	BTIG Research
9/30/2024	$13.00	Buy	Guggenheim
11/21/2023	$27.00	Buy	BTIG Research
9/27/2023	$21.00	Buy	B. Riley Securities
6/15/2023	$24.00 → $36.00	Neutral → Buy	Mizuho
9/7/2022	$6.00	Buy	Alliance Global Partners